|
|
|
|
Vol. 10, Issue 4, 975-986, April 1999
Department of Anatomy and Cell Biology, Gunma University School of Medicine, Maebashi 371-8511, Japan
Submitted November 30, 1998; Accepted February 3, 1999| |
ABSTRACT |
|---|
|
|
|---|
Caveolin-1 was discovered as a major substrate for v-Src, but the effect of its tyrosine phosphorylation has not been known. We generated a specific antibody (PY14) to caveolin-1 phosphorylated at tyrosine 14 and studied the significance of the modification. By Western blotting of lysates of v-Src-expressing cells, PY14 recognized not only a 22-kDa band (the position of nonphosphorylated caveolin-1) but bands at 23-24 and 25 kDa. Bands of slower mobility were diminished by dephosphorylation and were also observed for mutant caveolin-1 lacking tyrosine 14. By immunofluorescence microscopy, PY14 did not label normal cells but detected large dots in v-Src-expressing cells. Immunoelectron microscopy revealed that the dots corresponded to aggregated caveolae and/or vesicles of various sizes; besides, the label was observed in intramembrane particle-free areas in the plasma membrane, which appeared to have been formed by fusion of flattened caveolae. A positive reaction with PY14 was found in normal cells after vanadate or pervanadate treatment; it occurred mainly at 22 kDa by Western blotting and was not seen as large dots by immunofluorescence microscopy. Detergent solubility, oligomerization, and association with caveolin-2 were observed similarly for caveolin-1 in normal and v-Src-expressing cells. The results indicate that phosphorylation of caveolin-1 in v-Src-expressing cells occurs at multiple residues and induces flattening, aggregation, and fusion of caveolae and/or caveolae-derived vesicles.
| |
INTRODUCTION |
|---|
|
|
|---|
Caveolae are cell surface indentations found in many cell
types. Caveolae have been reported to contain various receptors, intracellular signaling molecules, and proteins related to
Ca2+ transport (for reviews, see Anderson, 1993
; Lisanti
et al., 1994
; Fujimoto et al., 1998
). They are
also thought to be related to intracellular cholesterol transport
(Smart et al., 1996
), endocytosis (Montesano et
al., 1982
), transcytosis (Milici et al., 1987
), and
potocytosis (Anderson et al., 1992
). It is beginning to
unfold that these diverse functions are correlated with each other
(Furuchi and Anderson, 1998
). Importantly, many of the putative
caveolae functions are related to caveolin-1 in one way or another;
thus analyzing its molecular characteristics appears indispensable for
an understanding of the function of caveolae.
Caveolin-1 is a principal protein of caveolae (Rothberg et
al., 1992
), and when cells without caveolae are transfected with its cDNA, de novo caveolae formation ensues (Fra et al.,
1995
). This molecule is assumed to take a hairpin loop conformation
with both N and C termini exposed to the cytoplasm (for review, see Parton, 1996
). Other characteristics of the molecule are the following: existence of two isoforms (
and
) with different lengths (Scherer et al., 1995
), binding to cholesterol (Murata et
al., 1995
), oligomerization (Monier et al., 1995
), and
serine and/or threonine phosphorylation by protein kinase C (Smart
et al., 1994
). All of these properties may influence the
structure and function of caveolae, but most notable is that caveolin-1
is phosphorylated in cells transformed by v-Src (Glenney and Zokas,
1989
) and is copurified with Src family tyrosine kinases from normal
cells (Sargiacomo et al., 1993
). But the direct consequence
of tyrosine phosphorylation of caveolin-1 has not been analyzed in detail.
There are nine tyrosine residues in the human caveolin-1 molecule,
three of which exist only in the
-isoform. It was shown previously
that the
isoform is selectively phosphorylated in v-Src-expressing
cells and that tyrosine 14 is the major phosphorylation site of c-Src
in vitro (Li et al., 1996b
). In the present study, we
generated an antibody that specifically recognizes caveolin-1 phosphorylated at tyrosine 14. By using the antibody, we performed immunohistochemical and biochemical characterization of the
tyrosine-phosphorylated caveolin-1. We found that caveolin-1 is
phosphorylated in multiple residues in v-Src-expressing cells and that
the modification leads to flattening, aggregation, and fusion of
caveolae and/or caveolae-derived vesicles; we also observed that a
similar but distinct molecular modification occurs in normal cells
after vanadate or pervanadate treatment. We assume that phosphorylation
of caveolin-1 by v-Src and other src family kinases could affect
caveolar functions through the morphological changes.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Cells
Normal rat fibroblasts (3Y1) and their Rous sarcoma virus
transformant (SR-3Y1) were obtained from Kimura's 3Y1 Library at RIKEN
Cell Bank (Tsukuba, Japan). Normal rat kidney (NRK) cells were also
obtained from RIKEN Cell Bank. The cells were grown in DMEM
(Nihonseiyaku, Tokyo, Japan) supplemented with 10% FBS, 50 U/ml
penicillin, and 0.05 mg/ml streptomycin at 37°C in 5% CO2. Temperature-sensitive v-Src
(srcts) NRK cells (Uehara et al.,
1984
) were kindly donated by Dr. Yoshimasa Uehara (National Institute
of Health, Tokyo, Japan) and cultured in DMEM added to 10% calf serum
at either 39°C (nonpermissive temperature) or 33°C (permissive temperature).
Antibodies
Anti-tyrosine 14-phosphorylated caveolin-1 antibody (PY14) was
raised by injecting rabbits with a tyrosine-phosphorylated peptide
(EGHLYTVPIRC) conjugated to keyhole limpet hemocyanin. The obtained
antiserum was purified by an affinity column bound with the antigen
peptide and then absorbed with a phosphotyrosine column to remove
nonspecific binding activity to other tyrosine-phosphorylated proteins.
Rabbit anti-phosphotyrosine antibody was kindly provided by Dr. Elena
Pasquale (Burnam Institute, La Jolla, CA). Rabbit polyclonal
anti-caveolin-1 antibodies (sc-894; Santa Cruz Biotechnology, Santa
Cruz, CA; C13630; Transduction Laboratories, Lexington, KY) and mouse
monoclonal anti-caveolin-1 antibodies (clones 2234, 2297, and C060;
Transduction Laboratories; clone Z034, Zymed Laboratories, South San
Francisco, CA) were also used; among these, two antibodies (sc-894 and
clone 2234) react with the
isoform alone, whereas the rest
recognize both
and
isoforms. Mouse anti-caveolin-2 antibody
(Transduction Laboratories), fluorescein- and rhodamine-conjugated donkey antibodies (Jackson ImmunoResearch, West Grove, PA), and colloidal gold-conjugated goat antibodies (Amersham, Buckinghamshire, United Kingdom) raised against mouse and rabbit immunoglobulin Gs were
obtained from the sources indicated.
Immunoprecipitation and Western Blotting
For immunoprecipitation, cells were treated with an ice-cold lysis buffer [1% Triton X-100, 60 mM octylglucoside, 25 mM Tris-HCl, 150 mM NaCl, 5 mM EDTA, 1 mM (p-amidinophenyl)methanesulfonyl fluoride (APMSF), 1 mM sodium orthovanadate, pH 7.5], precleared, and precipitated by antibodies prebound to agarose beads. Total cell lysates and immunoprecipitates were solubilized in an SDS-containing sample buffer, electrophoresed in acrylamide gels (13 or 5-15% gradient), and transferred to nitrocellulose paper. In some experiments, immunoprecipitated material or nitrocellulose paper after blotting was treated with 100 U/ml alkaline phosphatase (Takara Shuzo, Otsu, Japan) for 1 h at 33°C to examine the effect of dephosphorylation on antibody reactivity.
Production and Transfection of Mutant and Epitope-tagged Caveolin-1
The cDNA encoding human
-caveolin-1 was cloned by PCR and
inserted into pcDNA3.1 vector (Invitrogen, San Diego, CA). By using the
plasmid as a template, a point mutation to change tyrosine 14 to
asparagine was generated by a QuikChange site-directed mutagenesis kit
(Stratagene, La Jolla, CA) according to the manufacturer's protocol.
The product was further tagged with a c-myc epitope at the C terminus
and then used to transfect to 3Y1 and SR-3Y1 cells by lipofection.
Stably transfected cell lines were selected with G418 (Life
Technologies, Rockville, MD).
Immunofluorescence Microscopy
Cells cultured on glass coverslips were fixed with 3% formaldehyde in 0.1 M sodium phosphate buffer for 5 min, permeabilized with 1% Triton X-100 for 5 min, and pretreated with 3% BSA for 10 min. Some cells were treated with either 100 µM sodium orthovanadate for 2-8 h or 1 mM sodium orthovanadate plus 3 mM hydrogen peroxide (pervanadate) for up to 30 min before fixation. They were incubated with various primary antibodies, either singly or doubly, followed by fluorescein- and/or rhodamine-conjugated secondary antibodies. F-actin was labeled by rhodamine-phalloidin (Sigma Chemical, St. Louis, MO). The samples were observed under a Zeiss (Thornwood, NY) Axiophot 2 microscope.
Immunoelectron Microscopy
For immunolabeling of ultrathin cryosections, cells were fixed
with buffered 1% formaldehyde for 15 min, scraped, and embedded in
10% gelatin. They were then infiltrated with sucrose-polyvinyl pyrrolidone mixture, frozen, and sectioned (Tokuyasu, 1986
). For immunolabeling of freeze-fractured replicas, cells cultured on thin
gold foil were rapidly frozen by the metal sandwich method (Fujimoto
and Fujimoto, 1997
). The cell sandwich sample was freeze fractured in a
Balzers BAF060 apparatus (Balzers High Vacuum, Balzers, Liechtenstein),
and the obtained platinum and carbon replicas were then treated with
SDS (Fujimoto, 1995
) and incubated with BSA for blocking. Both
cryosections and freeze replicas were incubated with primary and
colloidal gold-conjugated secondary antibodies and observed under a
Jeol (Tokyo, Japan) 100CX electron microscope. Distribution of gold
particles was analyzed quantitatively on printed micrographs.
Analysis of Triton X-100 Solubility, Oligomer Formation, and Association with Caveolin-2
To study solubility of tyrosine-phosphorylated caveolin-1 in
Triton X-100, cells were treated with 1% Triton X-100 in
[N-morpholino]ethanesulfonic acid
(MES)-buffered saline (25 mM MES, 150 mM NaCl, 1 mM APMSF, 1 mM sodium
orthovanadate, pH 6.5) for 30 min on ice; after centrifugation at
15,000 rpm for 10 min, the pellet and supernatant were dissolved in the
same amount of SDS sample buffer for gel electrophoresis and Western
blotting. Oligomer formation was examined according to a published
procedure with some modification (Sargiacomo et al., 1995
).
Briefly, the Triton X-100-insoluble pellet was treated by a lysis
buffer (1% Triton X-100, 60 mM octylglucoside, 25 mM MES, 150 mM NaCl,
1 mM APMSF, 1 mM sodium orthovanadate, pH 6.5) for 20 min on ice and
centrifuged at 100,000 × g for 30 min. The supernatant
was layered onto a 5-30% linear sucrose gradient in the lysis buffer,
and centrifuged in an SW41 rotor (Beckman Instruments, Palo Alto,
CA) at 100,000 × g for 20 h at 4°C.
Fractions were collected, precipitated with cold acetone, and analyzed
by Western blotting. Association of caveolin-2 was examined by Western
blotting of materials immunoprecipitated by anti-caveolin-1 antibody.
| |
RESULTS |
|---|
|
|
|---|
Specificity of PY14
The credibility of the present study depends on the specificity of
the antibody to tyrosine-phosphorylated caveolin-1 (PY14). It was
necessary to show that the antibody recognizes only caveolin-1 phosphorylated at tyrosine 14 but not nonphosphorylated caveolin-1 or
other tyrosine-phosphorylated proteins. In Western blotting using
anti-
-caveolin-1 polyclonal antibody (sc-894), an intense band was
seen at 22 kDa for both normal fibroblast (3Y1) and its v-Src-expressing counterpart (SR-3Y1); in addition, a broad reaction with prominent bands at 23-24 and 25 kDa were observed only for SR-3Y1
(Figure 1A). In contrast, with PY14, no
reaction was seen for 3Y1, but an intense one occurred for SR-3Y1. The
bands ranged from 22 to 25 kDa and matched with those obtained with
sc-894 (22, 23-24, and 25 kDa). Notably, the most intense reaction
occurred at 22 kDa for sc-894, whereas it was at 25 kDa for PY14. In
srcts NRK cells, the reaction with PY14 became
apparent only after a few hours of culture at the permissive
temperature (Figure 1B). Furthermore, when the nitrocellulose membrane
blot with the total lysate of SR-3Y1 was treated with alkaline
phosphatase, reactivity with PY14 and anti-phosphotyrosine was lost,
but reaction with sc-894 remained (Figure 1C). In Western blotting of
the SR-3Y1 sample immunoprecipitated with sc-894, several bands between
22 and 25 kDa were labeled, but when the precipitate was
dephosphorylated before electrophoresis, the 23- to 24- and 25-kDa
bands were lost, and only the 22-kDa band was detected (Figure 1D).
These results show that PY14 recognizes caveolin-1 only when
phosphorylated at tyrosine 14 and that other residues were also
phosphorylated in the upper bands.
|
Notably several anti-caveolin-1 mAbs (clones 2297, C060, and
Z034) recognizing both
and
isoforms did not react well with the
isoform of v-Src-expressing cells (Figure 1E). When the 3Y1 and
SR-3Y1 samples were loaded to show an equivalent reaction to sc-894,
the
and
isoforms of 3Y1 were detected with equal intensity by
the mAbs; in contrast, the
isoform label was much denser than the
isoform one in SR-3Y1.
Localization of Tyrosine-phosphorylated Caveolin-1
By immunofluorescence microscopy using sc-894, the label was
observed as patches along the cell periphery in most 3Y1 cells (Figure
2A). In contrast, the peripheral patches
were scarcely found in SR-3Y1; instead, the label was seen as randomly
distributed dots, as reported previously (Figure 2B; Glenney and Zokas,
1989
). PY14 did not label 3Y1 positively (Figure 2C), but it labeled SR-3Y1 in a dot manner (Figure 2D). Large dots were observed more conspicuously by PY14 than by sc-894 and were distributed not only
along the cell surface but also in the cytoplasm. The labeling in
SR-3Y1 was eliminated by preincubating the antibody with the antigen
peptide. In srcts NRK cells, PY14 labeled only a
small percentage of the cells at the nonpermissive temperature (39°C;
Figure 2E); after 2 h of culture at the permissive temperature
(33°C), virtually all the cells became positive, but the labeling was
mostly seen as peripheral patches (Figure 2F); after 8 h at
33°C, the label was observed as large and small dots distributed
throughout the cell (Figure 2G). The distribution of PY14-positive
large dots in SR-3Y1 and srcts NRK cells was not
correlated with that of F-actin.
|
To examine the identity of the large dots at the ultrastructural level,
we immunolabeled SDS-treated freeze fracture replicas and ultrathin
cryosections. By both techniques, PY14 and sc-894 gave the same
labeling in v-Src-expressing cells. On freeze replicas, deep and
shallow caveolae were labeled positively (Figure
3, A and C) as shown previously for
caveolin-1 in other cell types (Fujimoto and Fujimoto, 1997
; Nomura
et al., 1997
). In addition, flat intramembrane particle
(IMP)-free areas, which were usually seen in the vicinity of typical
caveolae, were densely labeled (Figure 3, A and B). The size and shape
of the labeled area varied: some were round and as small as shallow
caveolae, whereas others took irregular shapes and were larger than
caveolae; the latter appeared to be formed by fusion of smaller
IMP-free areas. In contrast, normal NRK cells were not labeled by PY14;
in those cells, a majority of the sc-894 labeling was associated with
patches of deep and shallow caveolae, whereas truly flat IMP-free areas labeled by the antibody were scarce (Figure 3D). Moreover, in normal
NRK cells, the labeling in shallow caveolae occurred less densely than
that in deep ones, probably reflecting a differential expression of the
and
isoforms in caveolae of different depths (Fujimoto, Kogo,
Nomura, Takahashi, and Une, unpublished results). To address the
difference between normal and srcts NRK cells
quantitatively, the diameter of the sc-894-positive areas was
measured. Because deep caveolae were invariably <100 nm in diameter
and occurred in a large cluster only in normal NRK cells, their
inclusion distorted the comparison. Thus deep caveolae were excluded
from the quantification; even counting only the IMP-free flat areas and
shallow caveolae, the average size of the labeled area was
significantly smaller in normal NRK cells than in
srcts NRK cells (Figure
4).
|
|
In ultrathin cryosections, the result of freeze replica labeling in the
plasma membrane was confirmed: seemingly flat plasma membrane areas as
well as typical caveolae were labeled (Figure 5A). Furthermore, PY14 decorated
aggregates of caveolae and/or vesicles (collectively termed as
aggregated vesicles hereafter); some of them were of normal caveola
size, but others were apparently larger than caveolae (Figure 5, B-H).
The aggregates are likely to correspond to large dots seen by
immunofluorescence microscopy. They were seen either in the vicinity of
the plasma membrane (Figure 5, B-E) or deep in the cytoplasm (Figure
5, F-H). Even in sections as thin as 50 nm (interference color, gold),
the vesicles tend to be seen as overlapping membranes, and the
connection between their lumens was not apparent. Gold particles were
seen along the membrane of caveolae and caveolae-sized vesicles, but
they were often seen inside the larger vesicles (Figure 5, E and H). The size and distribution of sc-894-positive structures were
quantified and compared between normal and srcts
NRK cells; in srcts NRK cells, they were
distributed more distant from the plasma membrane and larger in
diameter than in normal NRK cells (Figure 6). Consistent with the result of freeze
fracture immunocytochemistry, the labeling in the seemingly flat plasma
membrane was also more frequent in srcts NRK
cells than in normal cells (Figure 6), although distinction between the
flat IMP-free areas and shallow caveolae could not be made in ultrathin
sections. We tried to observe the detailed ultrastructure of the
aggregated vesicles and to examine whether their lumen was open to the
cell surface by conventional electron microscopy. But it was difficult
to unequivocally identify the PY14-positive aggregated vesicles by
morphology alone.
|
|
Biochemical Characterization of PY14-positive Caveolin-1
Tyrosine phosphorylation may modify some of the molecular
properties of caveolin-1 and thus may lead to the change as described above. To study this possibility, we compared caveolin-1 taken from
SR-3Y1 with that from 3Y1 in terms of detergent solubility, oligomer
formation, and association with caveolin-2. Little caveolin-1 was
solubilized from 3Y1 cells by treatment of them with 1% Triton X-100
for 30 min at 4°C. The 22- to 25-kDa bands detected by PY14 in SR-3Y1
were also recovered in the insoluble fraction, and no difference from
nonphosphorylated caveolin-1 could be found (Figure 7A). Phosphorylated and nonphosphorylated
caveolin-1 was also not different in the solubility to 60 mM
octylglucoside (our unpublished results). Oligomer formation was
examined by sucrose density gradient ultracentrifugation of 3Y1 and
SR-3Y1 lysates in an octylglucoside-containing solution. Both samples
showed positive reaction in the 150- to 400-kDa fractions when probed
with sc-894 and/or PY14, and no significant difference was observed
(Figure 7B). Association with caveolin-2 was studied by Western
blotting of samples immunoprecipitated from lysates of 3Y1 and SR-3Y1.
The sc-894 precipitates of both 3Y1 and SR-3Y1 showed a positive
reaction for caveolin-2 (Figure 7C), indicating invariable association
of caveolin-1 and -2. The results indicate that tyrosine-phosphorylated
caveolin-1 may not be different from its nonphosphorylated counterpart
as far as detergent solubility, oligomer formation, and association
with caveolin-2 are concerned.
|
Mutant Caveolin-1 Lacking Tyrosine 14
To confirm that caveolin-1 is phosphorylated in residues
other than tyrosine 14 and to examine whether phosphorylation of tyrosine 14 is a prerequisite for further modifications, we constructed a mutant caveolin-1 tagged with c-myc, in which tyrosine 14 was replaced with asparagine, and used it to transfect 3Y1 and SR-3Y1 cells. By Western blotting using anti-c-myc antibody, one and three
positive bands were detected in 3Y1 and SR-3Y1 cells, respectively (Figure 8A). Judging from the relative
mobility, the one band in 3Y1 cells appeared to be the
isoform, and
the three bands in SR-3Y1 cells were considered the
isoform, the
isoform, and the modified
isoform from the bottom; although the
reason was not clear, the
isoform was hardly expressed in 3Y1
cells. When the immunoprecipitate of SR-3Y1 cells by sc-894 antibody was dephosphorylated before electrophoresis, the extra band above the
isoform was not detected by Western blotting using anti-c-myc antibody (Figure 8B). The result indicates that at least one residue other than tyrosine 14 is modified in v-Src-expressing cells and that
it occurs without phosphorylation of tyrosine 14.
|
Tyrosine Phosphorylation of Caveolin-1 in Normal Cells
When 3Y1 or normal NRK cells were incubated with vanadate or
pervanadate, which are inhibitors of tyrosine phosphatase, an intense
reaction with PY14 became visible by Western blotting. Pervanadate was
more effective than vanadate alone, but cells treated with it tended to
be detached from the substrate after several hours; thus to observe a
long-term effect, we used vanadate as the inhibitor. The reaction of
NRK cell lysates with PY14 was seen as a single band at 22 kDa after
2 h of vanadate treatment, and two additional bands at 23-24 and
25 kDa were also visible after 8 h (Figure
9A). Concurrently immunofluorescence
labeling by sc-894 changed. In untreated NRK cells, the label was seen mostly as peripheral patches (Figure 9B), but after 8 h of
vanadate treatment, the patches disappeared, and the labeling was
observed as small dots distributed randomly (Figure 9C). The cells
treated with vanadate for 2-8 h did not show bright immunofluorescence labeling with PY14, but those with pervanadate for 30 min were labeled
intensely (our unpublished results). In both cases, however, the large
dots observed to be labeled in v-Src-expressing cells were not
detected.
|
| |
DISCUSSION |
|---|
|
|
|---|
By raising a specific antibody to caveolin-1 phosphorylated at
tyrosine 14, we could analyze the distribution and molecular characteristics of the modified molecule in detail. The result of
Western blotting indicates that phosphorylation of caveolin-1 in
v-Src-expressing cells occurs not only at tyrosine 14 but also at
other residues; that is, there were several bands reactive with PY14 in
both SR-3Y1 and srcts NRK cells; at least one
upper band was detected even for the mutant caveolin-1 lacking tyrosine
14, and after dephosphorylation, caveolin-1 was detected as a single
band at 22 kDa. The possibility that the upper bands were modified
isoform was excluded, because all of them were recognized by
anti-
-caveolin-1 (sc-894). Phosphorylation sites besides tyrosine
14 are not known at present, but they could be serine (or threonine),
as reported in chicken cells (Glenney, 1989
), or tyrosine residues
other than tyrosine 14.
In v-Src-expressing cells, caveolin-1 showed a distribution different
from that in their normal counterpart: formation of patches along cell
edges was lost, and caveolin-1 occurred in large flat areas of the
plasma membrane and in aggregated vesicles in the cytoplasm. The freeze
fracture immunoelectron microscopy clearly showed that the flat areas
labeled by PY14 in the plasma membrane were demarcated by the absence
of IMPs and seen in the vicinity of caveolae. In normal cells, most
caveolin-1 labeling occurred in patches of deep and shallow caveolae as
observed previously (Fujimoto and Fujimoto, 1997
; Nomura et
al., 1997
), and labeled flat IMP-free areas were hardly seen. The
size of the caveolin-1-positive IMP-free areas in cells transformed by
v-Src was significantly larger than shallow caveolae or few flat
structures seen in their normal counterpart. Moreover, whereas shallow
caveolae were labeled by sc-894 only inefficiently in normal cells
(Fujimoto, Kogo, Nomura, Takahashi, and Une, unpublished
results), the IMP-free areas in v-Src-expressing cells were densely
labeled. Based on these results, we assume that the large
caveolin-1-positive IMP-free areas in v-Src-expressing cells are
distinct from shallow caveolae and probably formed by mutual fusion of
flattened caveolae.
The cytoplasmic structure labeled positively by PY14 looked like
racemose caveolae, that is, a group of caveolae sharing the lumen and
connected to the cell surface. Racemose caveolae have been described in
various cells in vivo (Bundgaard et al., 1983
; Bundgaard,
1991
) and in vitro (Parton et al., 1994
) and were induced in
cultured keratinocytes by disorganizing the actin cytoskeleton with
cytochalasin D (Fujimoto et al., 1995
). However, the
aggregated vesicles observed in the present study may be different from
racemose caveolae, because most of them did not appear to share the
lumen; moreover, many of them were found in the deep cytoplasm and thus were unlikely to be open to the cell surface; they were also different from racemose caveolae induced by cytochalasin D in that coaggregation of F-actin was not observed. The mechanism responsible for formation of
the aggregated vesicles is not known. But considering that membranes of
the vesicles are closely apposed in the aggregates and that flattened
caveolae in the plasma membrane appear to fuse, as discussed above, the
aggregated vesicles might be also formed by adhesion and fusion of
caveolae and/or caveolae-derived vesicles. As a result, some of them
may become larger vesicles, whereas others remain as caveola-sized
vesicles and are closely apposed to other ones.
We looked for changes in the molecular properties of caveolin-1 between
normal and v-Src-expressing cells, but detergent solubility, oligomer
formation, and association with caveolin-2 were found to be the same in
3Y1 and SR-3Y1 cells. Caveolin-1 is thought to form oligomers in the
endoplasmic reticulum (ER) before being transported through the Golgi
to the plasma membrane (Monier et al., 1995
). Because
tyrosine phosphorylation by myristylated v-Src is likely to occur at
the plasma membrane, only some but not all constituent caveolin-1
molecules in an oligomer may be modified. If this assumption is
correct, phosphorylated and nonphosphorylated molecules should coexist
in an oligomer, and the characteristics of phosphorylated molecules may
be masked in the biochemical experiments. Consistent with this,
immunolabeling with PY14 occurred in the same manner as that with
sc-894 in v-Src-expressing cells. But the negative result in the
present biochemical experiments does not exclude the possibility that
phosphorylation alters the molecular properties of caveolin-1 in some
aspects. In fact, by Western blotting, a battery of monoclonal
anti-caveolin-1 antibodies, whose epitopes are in a segment common to
the
and
isoforms, showed much lower reactivity to the
isoform than to the
isoform only in v-Src-expressing cells.
Because phosphorylation by v-Src was shown to occur in the
isoform-specific segment (Li et al., 1996b
), it is
peculiar that reactivity to the antibodies was reduced. The observation
might suggest that some conformational change of
-caveolin-1 occurs
as a result of multiple phosphorylation. Therefore, although the
caveolin-scaffolding domain, which is supposed to exert the regulatory
function of caveolin-1 on various proteins (Li et al.,
1996a
), is distant from the
-specific segment, its function
could be also modified in the phosphorylated molecule.
Besides the direct alteration of caveolin-1, various caveolar functions
may be changed by dissolution of patches, flattening in the plasma
membrane, and formation of the aggregated vesicles. First, the intimate
structural relationship between caveolae and the ER (Kogo et
al., 1997
) may be disrupted. Caveolae have been hypothesized to be
related to Ca2+ influx and extrusion (Fujimoto et
al., 1992
; Fujimoto, 1993
) and intracellular cholesterol transport
(Fielding and Fielding, 1995
; Smart et al., 1996
), whereas
the ER is thought to be a site of Ca2+ storage and the site
of de novo cholesterol synthesis (for reviews, see Pozzan et
al., 1994
; Fielding and Fielding, 1997
). Although speculative,
their close apposition might be related to their functional correlation
in Ca2+ regulation and cholesterol, and this relationship
may be changed in v-Src-expressing cells. Second, because a
significant proportion of caveolae-derived vesicles appear to be
sequestered from the cell surface in v-Src-expressing cells, receptors
and their downstream signaling molecules that reside in caveolae may be
separated from the extracellular milieu. The change may insulate cells
from various extracellular ligands. In oncogenically transformed cells,
expression of caveolin-1 and the number of caveolae were reported to
decrease (Koleske et al., 1995
). In contrast, the expression
of caveolin-1 was not much different between normal and
v-Src-expressing cells as far as examined by sc-894 in Western
blotting. The presence of caveolin-1 in the flat IMP-free plasmalemmal
areas as well as intracellular vesicles implies that an alteration of
caveolar function in transformed cells could occur without a drastic
reduction in caveolin-1 expression.
The present study confirmed the result on endothelial cells that
vanadate or pervanadate induces tyrosine phosphorylation of caveolin-1
in normal cells (Vepa et al., 1997
). Although the reaction of vanadate-treated NRK cell lysates with PY14 in Western blotting occurred in the same three bands (22, 23-24, and 25 kDa) as
in v-Src-expressing cells, it was most intense at 22 kDa, whereas the
25-kDa band was the strongest in v-Src-expressing cells, the difference most likely reflecting the difference in kinases
involved. Effects of tyrosine phosphorylation on caveolin-1
distribution in vanadate-treated cells were the same as in
v-Src-transformed cells in that peripheral patches disappeared but
were different in that the large dots corresponding to the aggregated
vesicles were not seen. In cultured endothelial cells, however, we
observed extensive vesiculation of caveolae after the vanadate
treatment (Aoki, Nomura, and Fujimoto, unpublished
observations). Different cells may have different sensitivity and/or
different machinery to respond to tyrosine phosphorylation of
caveolin-1. Thus, in contrast to v-Src-expressing cells, in which
extensive phosphorylation occurs, diverse phenomena might occur when
the level of tyrosine phosphorylation is relatively low.
In summary, the present study revealed the following results in v-Src-expressing cells: 1) caveolin-1 is phosphorylated not only in tyrosine 14 but also in other residues; 2) it is not distributed in peripheral patches as seen in normal cells but is found in IMP-free flat plasmalemmal areas and in aggregated caveolae and/or caveolae-derived vesicles; and 3) Triton X-100 insolubility, oligomer formation, and association with caveolin-2 persisted, but the molecular conformation may be altered. Caveolin-1 can be phosphorylated at tyrosine 14 in normal cells, but its consequence is different from that caused by v-Src. Tyrosine phosphorylation of caveolin-1 in v-Src-expressing cells has been considered a critical event for cellular transformation. Further analysis of its significance will be important for a better understanding of the physiology and pathology of caveolae.
| |
ACKNOWLEDGMENTS |
|---|
We are grateful to Dr. Yoshimasa Uehara for srcts NRK cells, to Dr. Elena Pasquale for anti-phosphotyrosine antibody, to Dr. Yoshimi Takai (Osaka University, Osaka, Japan) for continuous encouragement, and to Fujie Miyata and Yukiko Takahashi for excellent technical and secretarial assistance. R.N. also thanks Yoko Nomura, Santito Nomura, and Clara Nomura for continuous encouragement. This work was supported by grants-in-aid for scientific research from the Ministry of Education, Science, Sports, and Culture of the Japanese government and research grants from Suzuken Memorial Foundation and The Sagawa Foundation for Promotion of Cancer Research to T.F. and by research fellowships of the Japan Society for the Promotion of Science for Young Scientists to R.N.
| |
FOOTNOTES |
|---|
* Corresponding author. E-mail address: tfujimot{at}sb.gunma-u.ac.jp.
| |
REFERENCES |
|---|
|
|
|---|
application to the immunogold labeling of intercellular junctional complexes.
J. Cell Sci.
108, 3443-3450[Abstract].
subunits, and H-Ras share a common membrane-anchored scaffolding protein, caveolin. Caveolin binding negatively regulates the auto-activation of Src tyrosine kinases.
J. Biol. Chem.
271, 29182-29190
-isoform of caveolin is selectively phosphorylated by v-Src in vivo.
J. Biol. Chem.
271, 3863-3868
in the plasma membrane: a critical evaluation by immunocytochemistry.
FEBS Lett.
415, 139-144[Medline].This article has been cited by other articles:
![]() |
M. Jansen, V. M. Pietiainen, H. Polonen, L. Rasilainen, M. Koivusalo, U. Ruotsalainen, E. Jokitalo, and E. Ikonen Cholesterol Substitution Increases the Structural Heterogeneity of Caveolae J. Biol. Chem., May 23, 2008; 283(21): 14610 - 14618. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Nevins and D. C. Thurmond Caveolin-1 Functions as a Novel Cdc42 Guanine Nucleotide Dissociation Inhibitor in Pancreatic beta-Cells J. Biol. Chem., July 14, 2006; 281(28): 18961 - 18972. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Oh and D. C. Thurmond The Stimulus-induced Tyrosine Phosphorylation of Munc18c Facilitates Vesicle Exocytosis J. Biol. Chem., June 30, 2006; 281(26): 17624 - 17634. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Orlichenko, B. Huang, E. Krueger, and M. A. McNiven Epithelial Growth Factor-induced Phosphorylation of Caveolin 1 at Tyrosine 14 Stimulates Caveolae Formation in Epithelial Cells J. Biol. Chem., February 24, 2006; 281(8): 4570 - 4579. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. E. Martin, M. H. Elliott, R. S. Brush, and R. E. Anderson Detailed Characterization of the Lipid Composition of Detergent-Resistant Membranes from Photoreceptor Rod Outer Segment Membranes Invest. Ophthalmol. Vis. Sci., April 1, 2005; 46(4): 1147 - 1154. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Pol, S. Martin, M. A. Fernandez, M. Ingelmo-Torres, C. Ferguson, C. Enrich, and R. G. Parton Cholesterol and Fatty Acids Regulate Dynamic Caveolin Trafficking through the Golgi Complex and between the Cell Surface and Lipid Bodies Mol. Biol. Cell, April 1, 2005; 16(4): 2091 - 2105. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Radel and V. Rizzo Integrin mechanotransduction stimulates caveolin-1 phosphorylation and recruitment of Csk to mediate actin reorganization Am J Physiol Heart Circ Physiol, February 1, 2005; 288(2): H936 - H945. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Labrecque, C. Nyalendo, S. Langlois, Y. Durocher, C. Roghi, G. Murphy, D. Gingras, and R. Beliveau Src-mediated Tyrosine Phosphorylation of Caveolin-1 Induces Its Association with Membrane Type 1 Matrix Metalloproteinase J. Biol. Chem., December 10, 2004; 279(50): 52132 - 52140. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Pietiainen, V. Marjomaki, P. Upla, L. Pelkmans, A. Helenius, and T. Hyypia Echovirus 1 Endocytosis into Caveosomes Requires Lipid Rafts, Dynamin II, and Signaling Events Mol. Biol. Cell, November 1, 2004; 15(11): 4911 - 4925. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kogo, T. Aiba, and T. Fujimoto Cell Type-specific Occurrence of Caveolin-1{alpha} and -1{beta} in the Lung Caused by Expression of Distinct mRNAs J. Biol. Chem., June 11, 2004; 279(24): 25574 - 25581. [Abstract] [Full Text] [PDF] |
||||
![]() |
G.D. Norata, E. Callegari, H. Inoue, and A.L. Catapano HDL3 Induces Cyclooxygenase-2 Expression and Prostacyclin Release in Human Endothelial Cells Via a p38 MAPK/CRE-Dependent Pathway: Effects on COX-2/PGI-Synthase Coupling Arterioscler. Thromb. Vasc. Biol., May 1, 2004; 24(5): 871 - 877. [Abstract] [Full Text] |
||||
![]() |
S. Ge and J. S. Pachter Caveolin-1 Knockdown by Small Interfering RNA Suppresses Responses to the Chemokine Monocyte Chemoattractant Protein-1 by Human Astrocytes J. Biol. Chem., February 20, 2004; 279(8): 6688 - 6695. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Labrecque, I. Royal, D. S. Surprenant, C. Patterson, D. Gingras, and R. Beliveau Regulation of Vascular Endothelial Growth Factor Receptor-2 Activity by Caveolin-1 and Plasma Membrane Cholesterol Mol. Biol. Cell, January 1, 2003; 14(1): 334 - 347. [Abstract] [Full Text] |
||||
![]() |
G. Brown, H. W. McL. Rixon, and R. J. Sugrue Respiratory syncytial virus assembly occurs in GM1-rich regions of the host-cell membrane and alters the cellular distribution of tyrosine phosphorylated caveolin-1 J. Gen. Virol., August 1, 2002; 83(8): 1841 - 1850. [Abstract] [Full Text] [PDF] |